Apollomics Inc.

03/18/2026 | Press release | Distributed by Public on 03/18/2026 16:33

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Chen Yi-Kuei
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [APLM]
(Last) (First) (Middle)
989 E HILLSDALE BLVD, SUITE 220
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Operating Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
FOSTER CITY 94404
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Class A Ordinary Shares 101,248 I By Maxpro Investment Co., Ltd.(1)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) (2) Class A Ordinary Shares 20,000 (3) D
Warrants 04/28/2023 03/29/2028 Class A Ordinary Shares 3,823(4) $1,150(4) I By Maxpro Investment Co., Ltd.(1)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Chen Yi-Kuei
989 E HILLSDALE BLVD, SUITE 220
FOSTER CITY 94404
X Chief Operating Officer

Signatures

/s/ Yi-Kuei (Alex) Chen 03/18/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reporting person is member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. The reporting person disclaims beneficial ownership of theses securities except to the extent of his pecuniary interest therein.
(2) The restricted stock units were vested with respect to 5,000 shares on February 17, 2026, with an additional 5,000 shares vesting on each of May 17, 2026, August 17, 2026 and November 17, 2026.
(3) Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.
(4) Reflects the adjusted exercise price of $1,150.00 per full share, as each warrant is exercisable for 0.01 Class A Ordinary Share at a price of $11.50 per warrant.

Remarks:
This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Apollomics Inc. published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 18, 2026 at 22:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]